ANDA 211315, held by Aurobindo Pharma Ltd. Triamcinolone Acetonide.
As of Nov 15, 2026, ANDA 211315 (Triamcinolone Acetonide), held by Aurobindo Pharma Ltd, was first approved by FDA on Mar 18, 2020, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 18, 2020 | Original application | Approved | None posted |
| Triamcinolone Acetonide0.1% · ointment;topical | Triamcinolone Acetonide | Discontinued |
| Triamcinolone Acetonide0.5% · ointment;topical | Triamcinolone Acetonide | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
